Blood hemoglobin level may affect radiosensitivity—preliminary results on acutely reacting normal tissues
- 1 September 2000
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 48 (2) , 339-345
- https://doi.org/10.1016/s0360-3016(00)00595-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Erythropoietin in Radiation Oncology – A ReviewOncology, 2000
- A prospective study of the risk of transfusion‐acquired viral infectionsTransfusion Medicine, 1998
- Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: A review of the institute gustave roussy experienceInternational Journal of Radiation Oncology*Biology*Physics, 1997
- 452: Hemoglobin levels predict local regional control after postoperative radiotherapy for advanced head and neck cancerEuropean Journal Of Cancer, 1997
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- Erythropoietin increases hemoglobin during radiation therapy for cervical cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85Radiotherapy and Oncology, 1991
- Radiotherapy and anaemia — the clinical experienceRadiotherapy and Oncology, 1991
- Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervixInternational Journal of Radiation Oncology*Biology*Physics, 1989
- The significance of anemia in clinical radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1986